SWOT Analysis for Nectar Lifesciences Ltd.

Benjamin Graham Value Screen
Price crossing above SMA20 today, and greater than SMA5
Strong Performer, Under Radar Stocks (DVM)
Value Stocks, Under Radar (DVM)
Rising Net Cash Flow and Cash from Operating activity
Companies with high TTM EPS Growth
Strong Annual EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Companies with rising net profit margins - quarterly as well as TTM basis
Affordable Stocks - Stocks with Good Trendlyne Valuation Score
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 3 quarters
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
High Volume, High Gain
Biggest Price Gainers from Open
Top Gainers
Volume Shockers

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Companies with High Promoter Pledge
Highest fall from 52 Week High
High promoter stock pledges
Stocks Underperforming their Industry Price Change in the Quarter